Sensei Biotherapeutics
SNSE
SNSE
39 hedge funds and large institutions have $7.06M invested in Sensei Biotherapeutics in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
56% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 16
Holders
39
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.64M | |
| 2 | +$942K | |
| 3 | +$372K | |
| 4 |
E
Ergoteles
New York
|
+$212K |
| 5 |
Millennium Management
New York
|
+$191K |
Top Sellers
| 1 | -$2.24M | |
| 2 | -$457K | |
| 3 | -$371K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$358K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$312K |